Advertisement

Biochemical Markers in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma

  • J. A. Child
  • E. H. Cooper
  • S. Illingworth
  • T. S. Worthy
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 64)

Abstract

It has been known for many years that the concentration of a number of plasma proteins may be subject to acute change, for example, following surgical trauma [6, 7, 26]; hence the term ‘acute phase’ reactant protein (APRP). Many of these proteins are glycoproteins travelling electrophorectically in the α-region and are made in the liver. The biological function of only some of them is fully understood and their metabolism also requires elucidation. All of them are detectable in the plasma of healthy subjects with the notable exception of C-reactive protein, which is usually absent. The study of these proteins, encouraged by improved specificity in measurement, has been extended to a variety of disease states not necessarily limited to acute phenomena. An important observation is that dissociated increases of particular APRPs have a discriminant function; for example, while in neoplastic invasion of the liver, α1-antitrypsin and α1-acid glycoprotein are both increased, there is dissociation in hepatitis and cirrhosis [10, 11]. The study of ulcerative colitis and Crohn’s disease has illustrated the value of studying a protein profile in which as many as eight proteins are estimated [16]. Investigation of protein profiles in various types of malignant disease [2, 4, 5, 15, 17, 18] suggests that they may be of value in several ways: they show promise in terms of the staging of some diseases, they can be of value in the early warning and monitoring of metastatic disease, and they may be able to discriminate between inflammatory/infective and neoplastic processes.

Keywords

Electron Spin Resonance Protein Profile Reflect Disease Activity Recent Relapse Serum Gamma Glutamyl Transpeptidase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W., Tubiana, M.: Report of the Committee on Hodgkin’s disease staging classification. Cancer Res. 31, 1860–1861 (1971).PubMedGoogle Scholar
  2. 2.
    Child, J. A., Roberts, B. E., Illingworth, S., Cooper, E. H.: Acute phase reactant proteins in chronic leukaemia. Biomedicine 27, 188–189 (1977).PubMedGoogle Scholar
  3. 3.
    Cooper, E. H., Turner, R., Steele, L., Neville, A. M., Mackay, A. M.: The contribution of serum enzyme and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer. Br. J. Cancer 31, 111–117(1975).PubMedCrossRefGoogle Scholar
  4. 4.
    Coope., E. H., Turner, R., Geekie, A., Munro Neville, A., Goligher, J. C., Graham, N. G., Giles, G. R., Hall, R., Macadam, W.A.F.: Alpha-globulins in the surveillance of colorectal cancer. Biomedicine 24, 171–178 (1976a).Google Scholar
  5. 5.
    Cooper, E. H., Turner, R., Milford-Ward, A., Neville, A. M.: Multiparametric tests in the monitoring of cancer. In: Cancer Related Antigens. Franchimont, P. (ed.) Amsterdam-New York-Oxford: North-Holland 1976b, pp. 179–186.Google Scholar
  6. 6.
    Crockson, R. A., Payne, C. J., Ratcliff, A. P., Soothill, J. F.: Time sequence of acute phase reactive proteins following surgical trauma. Clin. Chim. Acta 14 ,435–441 (1966).PubMedCrossRefGoogle Scholar
  7. 7.
    Fischer, C. L., Gill, C., Forrester, M. G., Nakamura, R.: Quantitation of “Acute-phase proteins” postoperatively-Value in detection and monitoring complications. Am. J. Clin. Pathol. 66, 840–846 (1976).PubMedGoogle Scholar
  8. 8.
    Foster, M., Fell, L., Pocklington, T., Akinsete, F., Dawson, A., Hutchison, J. M. S., Mallard, J. R.: Electron spin resonance as a useful technique in the management of Hodgkin’s disease. Clin. Radiol. 28, 15–22 (1977a).PubMedCrossRefGoogle Scholar
  9. 9.
    Foster, M., Dawson, A., Pocklington, T., Fell, L.: Electron spin resonance measurements of blood caeruloplasmin and iron transferrin levels in patients with non-Hodgkin’s lymphoma. Clin. Radiol. 28, 23–28 (1977b).PubMedCrossRefGoogle Scholar
  10. 10.
    Giusti, G., Piccinino, F., Sagnelli, E., Pasquale, G.: Differential diagnosis between benign and malignant biliary tract obstruction. Discriminative usefulness of some clinical and laboratory data. Acta Hepatogastroenterol. (Stuttg.) 22, 374–379 (1975).Google Scholar
  11. 11.
    Hiramatsu, S., Kojina, J., Okada, T. T., Inai, S., Ohmori, K.: The serum protein profile in chronic hepatitis, cirrhosis and liver cancer. Acta Hepatogastroenterol. (Stuttg.) 23 ,177–182 (1976).Google Scholar
  12. 12.
    Hutchinson, R. M., Eastham, R. D.: A comparison of the erythrocyte sedimentation rate and plasma viscosity in detecting changes in plasma proteins. J. Clin. Pathol. 30, 345–349 (1977).PubMedCrossRefGoogle Scholar
  13. 13.
    Jacobs, A., Worwood, M.: Ferritin: clinical aspects. In: Iron Metabolism and its Disorders. Kief, H. (ed.) Amsterdam-Oxford: Excerpta Medica 1975, Vol. III, pp. 90–95.Google Scholar
  14. 14.
    Kaplan, H. S.: Hodgkin’s disease and other human malignant lymphomas: Advances and Prospects-G.H.A. Clowes Memorial Lecture. Cancer Res. 36, 3863–3878 (1976).PubMedGoogle Scholar
  15. 15.
    Koj, A.: “Acute-phase reactants.” In: The Structure and Function of Plasma Proteins. Allison, A. C. (ed.) New York: Plenum Press 1975, Vol. I, pp. 73–132.Google Scholar
  16. 16.
    Milford-Ward, A.: Personal communication.Google Scholar
  17. 17.
    Milford-Ward, A., Cooper, E. H., Turner, R., Anderson, J. A., Neville, A. M.: Acute-phase Reactant Protein Profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br. J. Cancer 35 ,170–178(1977).CrossRefGoogle Scholar
  18. 18.
    Neville, A. M., Cooper, E. H.: Biochemical monitoring of cancer. Ann. Clin. Biochem. 13, 283–305 (1976).PubMedGoogle Scholar
  19. 19.
    Pagliardi, E., Giangrandi, E.: Clinical significance of the blood copper in Hodgkin’s disease. Acta Haematol. (Basel) 24, 201–212 (1960).CrossRefGoogle Scholar
  20. 20.
    Ray, R. G., Wolf, P. H., Kaplan, H. S.: Value of laboratory indicators in Hodgkin’s disease: Preliminary Results. Natl. Cancer Inst. Monogr. 36, 315–323 (1973).PubMedGoogle Scholar
  21. 21.
    Roberts, B. E., Child, J. A., Cooper, E. H., Turner, R., Stone, J.: An evaluation of the usefulness of serum gamma glutamyl transpeptidase levels in the management of haematological neoplasia. Acta Haematol. (Basel) 59, 65–72 (1978).CrossRefGoogle Scholar
  22. 22.
    Shuster, J., Gold, P., Poulik, M. D. L.: β2-Microglobulin levels in cancerous and other disease states. Clin. Chim. Acta 67, 307–313 (1976).PubMedCrossRefGoogle Scholar
  23. 23.
    Simmons, A. V., Spiers, A. S. D., Fayers, P. M.: Haematological and clinical parameters in assessing activity in Hodgkin’s disease and other malignant lymphomas. Q. J. Med. (New Series) 42, 111–124 (1973).Google Scholar
  24. 24.
    Teillet, F., Boiron, M., Bernard, J.: A reappraisal of clinical and biological signs in staging of Hodgkin’s disease. Cancer Res. 31, 1723–1729 (1971).PubMedGoogle Scholar
  25. 25.
    Warren, R. L., Jellife, A. M., Watson, J. V., Hobbs, C. B.: Prolonged observations on variations in serum copper in Hodgkin’s disease. Clin. Radiol. 20, 247–256 (1969).PubMedCrossRefGoogle Scholar
  26. 26.
    Werner, M.: Serum protein changes during the acute-phase reaction. Clin. Chim. Acta 25, 299–305 (1969).PubMedCrossRefGoogle Scholar
  27. 27.
    Whitfield, J. B., Pounder, R. E., Neale, G., Moss, D. W.: Serum γ-glutamyl transpeptidase activity in liver disease. Gut 13, 702–708 (1972).PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1978

Authors and Affiliations

  • J. A. Child
  • E. H. Cooper
  • S. Illingworth
  • T. S. Worthy

There are no affiliations available

Personalised recommendations